Short-term Clinical and Microbiological Performance of Resin-modified Glass Ionomer Cement Containing Chlorhexidine for Atraumatic Restorative Treatment.

Aim: This study evaluated the short-term clinical and microbiological performance of resin-modified glass ionomer cement (RM-GIC) cement containing chlorhexidine (CHX) for atraumatic restorative treatment (ART) in primary teeth.

Materials And Methods: The clinical trial was conducted in 36 children that received ART in primary molars either with GIC (group I, = 18) or GIC containing 1.25% CHX (group II, = 18).